Clearside Biomedical names Lester Rodriguez as VP of quality

boardroom-background-2.jpg

Clearside Biomedical (NASDAQ:CLSD) appointed Lester Rodríguez as VP of quality as the company prepares to transition from a clinical-stage to a commercial-stage company.

Before joining Clearside, Mr. Rodríguez was VP of quality for Pharma Tech Industries, the world’s largest pharmaceutical contract manufacturer and packager of powder products. He also has quality and manufacturing leadership roles at various pharmaceutical companies, including Ciba Vision, Novartis Ophthalmics and Shionogi.

Mr. Rodríguez, who has more than 30 years of experience in the pharmaceuticals industry, will be responsible for ensuring that Clearside continues to design and implement appropriate programs, policies and procedures related to quality assurance and quality control activities across the company and its suppliers.

In addition, he will provide cross-functional compliance oversight of activities involving all recognized quality standards for the pharmaceutical industry, such as good manufacturing and good clinical practices.

“As we plan for the potential commercial launch of our first product, and continue to develop our pipeline of advanced and pre-clinical product candidates, it is important that both Clearside and our suppliers continue to do everything we can to ensure strict quality control and regulatory compliance in our operations,” CEO and president, Daniel White, said in a statement.

Sydney Stewart